ImmuCell Corporation (ICCC) earnings
ICCC earnings moved a median of -1.61% by the close. Quarterly and annual ICCC reports and results, each read against the price at its own news timestamp. Back to the ICCC overview →
12 measured ICCC earnings events.
Where these ICCC earnings landedvs 12 measured ICCC earnings reactions
| Middle 50% of ICCC earnings reactions | -4.94% to -0.59% |
|---|---|
| Median reaction (to close) | -1.61% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 ICCC earnings events with a measured close landed between -4.94% and -0.59%; 17% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IMMUCELL CORP /DE/ For: Jun 30 | SEC filing · Form 10-Q | -2.80% | -6.25% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Mar 31 | SEC filing · Form 10-Q | +3.35% | +6.19% | |
| Form 10-K/A IMMUCELL CORP /DE/ For: Dec 31 | SEC filing · Form 10-K | — | -0.84% | |
| Form 10-K IMMUCELL CORP /DE/ For: Dec 31 | SEC filing · Form 10-K | — | -0.78% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Jun 30 | SEC filing · Form 10-Q | — | -13.92% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Mar 31 | SEC filing · Form 10-Q | -2.00% | -4.50% | |
| Form 10-K IMMUCELL CORP /DE/ For: Dec 31 | SEC filing · Form 10-K | — | -4.20% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Sep 30 | SEC filing · Form 10-Q | -0.43% | +2.86% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Jun 30 | SEC filing · Form 10-Q | +3.54% | -1.91% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Mar 31 | SEC filing · Form 10-Q | -6.78% | -8.10% | |
| Form 10-K IMMUCELL CORP /DE/ For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.32% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Sep 30 | SEC filing · Form 10-Q | +0.97% | +0.00% |
Keep exploring
More ICCC: analyst actions → · SEC filings → · ICCC overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) | 159 | -1.80% | 36% |
| GT Biopharma, Inc. (GTBP) | 159 | -0.91% | 32% |
| CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN) | 158 | -1.25% | 25% |
| NeuroMetrix, Inc. (NURO) | 157 | -0.49% | 30% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.